Uploaded July 2026 | Updated November 2026, 1 day ago
Researchers from WEHI and global biopharmaceutical company MSD have been named joint finalists for the Eureka Prize for Infectious Diseases Research.
The nomination recognises the team's discovery and development of a new class of drug compounds designed to overcome drug resistance and reduce the spread of malaria.
Read the full story: https://www.wehi.edu.au/news/from-lab-to-clinic-malaria-researchers-earn-eureka-nomination/
Researchers from WEHI and global biopharmaceutical company MSD have been named joint finalists for the Eureka Prize for Infectious Diseases Research.
The nomination recognises the team's discovery and development of a new class of drug compounds designed to overcome drug resistance and reduce the spread of malaria.
Read the full story: https://www.wehi.edu.au/news/from-lab-to-clinic-malaria-researchers-earn-eureka-nomination/










